BlackRock
SONM icon

BlackRock’s DNA X Inc SONM Stock Holding History

BlackRock’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.4K Hold
14,006
– – ﹤0.01% 5100
2025
Q4 		$44.1K Sell
14,006
-1
-0% -$9 ﹤0.01% 5081
2025
Q3 		$152K Buy
+14,007
New +$162K ﹤0.01% 4738
2024
Q2 		– Sell
-268
Closed -$29.4K – 5345
2024
Q1 		$29.4K Sell
268
-6
-2% -$738 ﹤0.01% 4977
2023
Q4 		$36.3K Sell
274
-4
-1% -$531 ﹤0.01% 5014
2023
Q3 		$33.5K Sell
278
-7
-2% -$977 ﹤0.01% 5073
2023
Q2 		$59K Buy
+285
New +$55.6K ﹤0.01% 5038
2020
Q3 		– Hold
0
– – – 5157
2020
Q2 		– Sell
-101
Closed -$161K – 5120
2020
Q1 		$128K Sell
101
-135
-57% -$647K ﹤0.01% 4313
2019
Q4 		$1.54M Buy
236
+138
+141% +$681K ﹤0.01% 3863
2019
Q3 		$515K Buy
98
+7
+8% +$107K ﹤0.01% 4161
2019
Q2 		$2.08M Buy
+91
New +$2.31M ﹤0.01% 3772

Other funds holding SONM

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CWM
C2C Wealth Management Scottsdale, Arizona $128M AUM 22.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

BlackRock's SONM Position: Q1 2026 in Review

BlackRock held its DNA X Inc (SONM) position steady in Q1 2026 at 14,006 shares worth $56.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5100.

BlackRock first reported a position in SONM in Q2 2019 and has held it in 11 quarters since. The position peaked at $2.08M in Q2 2019. 9 funds tracked by Wall St. Rank hold SONM as of Q1 2026.

  • BlackRock held 14,006 shares of DNA X Inc worth $56.4K as of Q1 2026.
  • BlackRock left its DNA X Inc share count unchanged in Q1 2026.
  • DNA X Inc made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5100 holding.
  • BlackRock first reported a position in DNA X Inc in Q2 2019 and has held it in 11 quarters since.
  • BlackRock's DNA X Inc position peaked at $2.08M in Q2 2019.
  • 9 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.